Physician profile
Garth Graham
NPI 1427252584
$32,341.49
in general payments reported to CMS, 2019-2025
5 companies · $4,094 in 2025
The $4,094 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14K · 2022: $6,134 · 2023: $2,858 · 2024: $5,080 · 2025: $4,094.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,731 · Honoraria: $3,300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,731.25 |
| Honoraria | $3,300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $12,333.90 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $8,731.25 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $4,256.34 | 2021 | |
| Ucb Gmbh | $3,720.00 | 2021 | |
| Philips North America LLC | $3,300.00 | 2025 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garth Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.